Summary
Noradrenaline, adrenaline, isoprenaline and salbutamol induced marked accumulations of cyclic AMP in incubated slices of chick cerebral hemispheres. Isoprenaline was both more potent and more powerful than adrenaline or noradrenaline and the increase in cyclic AMP elicited by the catecholamines was powerfully antagonised by the β-adrenoceptor antagonist propranolol but not by the α-adrenoceptor blocker phentolamine. The order of potency of the catecholamines isoprenaline > adrenaline > noradrenaline and the ability of the noncatechol salbutamol to stimulate cyclic AMP accumulation in chick cerebral slices suggests that the β-adrenoceptor may resemble that found in the lung (β2) rather than that in the heart (β1).
Propranolol proved to be a very potent antagonist of the cyclic AMP response induced by isoprenaline in vivo. β-adrenoceptor blockade was still evident 12 hrs after a single injection of the drug although only negligible amounts of 3H-propranolol could be detected in cerebral tissue after 2 hrs.
Similar content being viewed by others
References
Barrett, A. M., Cullen, V. A.: The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Brit. J. Pharmacol. 34, 43–55 (1968)
Bloom, F. E., Chu, N. S., Hoffer, B. J., Nelson, C. H., Siggins, G. R.: Studies on the function of central noradrenergic neurons. Neurosci. Res. 5, 53–72 (1973)
Brown, B. L., Albano, J. D. M., Ekins, R. P., Sgherzi, A. M.: A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem. J. 121, 561–562 (1971)
Burges, R. A., Blackburn, K. J.: Adenyl cyclase and the differentiation of β-adrenoceptors. Nature (New Biol.) 235, 249–250 (1972)
Chasin, M., Rivkin, I., Mamrak, F., Samaniego, S. G., Hess, S. M.: α- and β-adrenergic receptors as mediators of accumulation of cyclic adenosine 3′,5′-monophosphate in specific areas of guinea pig brain. J. biol. Chem. 246, 3037–3041 (1971).
Daly, J. W.: Cyclic adenosine 3′,5′-monophosphate role in the physiology and pharmacology of the central nervous system. Biochem Pharmacol. 24, 159–164 (1975)
Edwards, C., Nahorski, S. R., Rogers, K. J.: In vivo changes of cerebral cyclic adenosine 3′,5′-monophosphate induced by biogenic amines: association with phosphorylase activation. J. Neurochem. 22, 565–572 (1974)
Farmer, J. B., Kennedy, I., Levy, G. P., Marshall, R. J.: A comparison of the β-adrenoceptor stimulant properties of isoprenaline with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea-pig. J. Pharm. Pharmacol. 22, 61–63 (1970)
Gilman, A. G., Nirenberg, M.: Effect of catecholamines on the adenosine 3′,5′-cyclic monophosphate concentrations of clonal satellite cells of neurons. Proc. nat. Acad. Sci. (Wash.) 68, 2165–2168 (1971)
Gilman, A. G., Schrier, B. K.: Adenosine cyclic 3′,5′-monophosphate in foetal rat brain cell cultures. 1. Effect of catecholamines. Molec. Pharmacol. 8, 410–416 (1972)
Greengard, P., Kebabian, J. W.: Role of cyclic AMP in synaptic trasmission in the mammalian peripheral nervous system. Fed. Proc. 33, 1059–1067 (1974)
Hayes, A., Cooper, R. G.: Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey. J. Pharmacol. exp. Ther. 176, 302–311 (1971)
Ikeda, H., Gotoh, J.: Distribution of monoamine containing terminals and fibers in the central nervous system of the chicken. Jap. J. Pharmacol. 24, 831–841 (1974)
Kakiuchi, S., Rall, T. W.: The influence of chemical agents on the accumulation of adenosine 3′,5′-phosphate in slices of rabbit cerebellum.Molec. Pharmacol. 4, 367–378 (1968)
Kalisker, A., Rutledge, C. O., Perkins, J. P.: Effect of nerve degeneration by 6-hydroxydopamine on catecholamine-stimulated adenosine 3′,5′-monophosphate formation in rat cerebral cortex. Molec. Pharmacol. 9, 619–629 (1973)
Kodama, T., Matsukado, Y., Shimizu, H.: The cyclic AMP system of human brain. Brain Res. 50, 135–146 (1973)
Krishna, G., Weiss, B., Brodie, B. B.: A simple sensitive method for the assay of adenyl cyclase. J. Pharmacol. exp. Ther. 163, 379–385 (1968)
Levitki, A., Atlas, D., Steer, M. L.: The binding characteristics and number of β-adrenergic receptors on the turkey erythrocyte. Proc. nat. Acad. Sci. (Wash.) 71, 2773–2776 (1974)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurements with the Folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Nahorski, S. R., Rogers, K. J.: The adenosine 3′,5′-monophosphate content of brain tissue obtained by an ultra-rapid freezing technique. Brain Res. 51, 332–336 (1973)
Nahorski, S. R., Rogers, K. J., Smith, B. M.: Regulation of the cyclic AMP concentration in chick brain by β-adrenoceptors and histamine H2 receptors. Brit. J. Pharmacol. 52, 121 P (1974)
Perkins, J. P., Moore, M. M.: Characterisation of the adrenergic receptors mediating a rise in cyclic 3′,5′-adenosine monophosphate in rat cerebral cortex. J. Pharmac. exp. Ther. 185, 371–378 (1973)
Robison, G. A., Butcher, R. W., Sutherland, E. W.: Cyclic AMP. New York: Academic Press 1971
Sattin, A., Rall, T. W., Zanella, J.: Regulation of cyclic adenosine 3′,5′-monophosphate levels by interaction of alpha adrenergic and adenosine receptor activity. J. Pharmacol. exp. Ther. 192, 22–32 (1975)
Schultz, J., Daly, J. W.: Adenosine 3′,5′-monophosphate in guinea pig cerebral cortical slices: Effects of α- and β-adrenergic agents, histamine, serotonin and adenosine. J. Neurochem. 21, 573–579 (1973a)
Schulz, J., Daly, J. W.: Accumulation of cyclic adenosine 3′5′-monophosphate in cerebral cortical slices from rat and mouse: stimulating effect of α- and β-adrenergic agents and adenosine. J. Neurochem. 21, 1319–1326 (1973b)
Schultz, J., Kleefeld, G.: Stimulation of adenosine 3′,5′-monophosphate formation in guinea-pig cerebral cortical slices in a calcium free medium. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 289–296 (1975)
Snyder, S. H.: The glycine synaptic receptor in the mammalian central nervous system. Brit. J. Pharmacol. 53, 473–484 (1975)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology 12, 1073–1080 (1973)
Stephenson, R. P.: A modification of receptor theory. Brit. J. Pharmacol. 11, 379–393 (1956)
Veech, R. L., Harris, R. L., Veloso, D., Veech, E. H.: Freeze-blowing: A new technique for the study of brain in vivo. J. Neurochem. 20, 183–188 (1973)
Von Hungen, K., Roberts, S.: Adenylate-cyclase receptors for adrenergic neurotransmitters in rat cerebral cortex. Europ. J. Biochem. 36, 391–401 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nahorski, S.R., Rogers, K.J., Smith, B.M. et al. Characterisation of the adrenoceptor mediating changes in cyclic adenosine 3′—5′ monophosphate in chick cerebral hemispheres. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 101–110 (1975). https://doi.org/10.1007/BF00510824
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00510824